Log In
Print this Print this

ATH012, NT-KO-003

  Manage Alerts
Collapse Summary General Information
Company Advancell Advanced In Vitro Cell Technologies S.A.
DescriptionNeuroprotective, non-immunosuppressive molecule in a film-coated tablet
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationMultiple sclerosis (MS)
Indication DetailsTreat multiple sclerosis (MS)
Regulatory Designation
PartnerNeurotec Pharma S.L.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today